1. Home
  2. YQ vs BRTX Comparison

YQ vs BRTX Comparison

Compare YQ & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YQ
  • BRTX
  • Stock Information
  • Founded
  • YQ 2012
  • BRTX 1997
  • Country
  • YQ China
  • BRTX United States
  • Employees
  • YQ N/A
  • BRTX N/A
  • Industry
  • YQ Other Consumer Services
  • BRTX Managed Health Care
  • Sector
  • YQ Real Estate
  • BRTX Health Care
  • Exchange
  • YQ Nasdaq
  • BRTX Nasdaq
  • Market Cap
  • YQ 14.9M
  • BRTX 10.7M
  • IPO Year
  • YQ 2020
  • BRTX N/A
  • Fundamental
  • Price
  • YQ $1.95
  • BRTX $1.54
  • Analyst Decision
  • YQ
  • BRTX Strong Buy
  • Analyst Count
  • YQ 0
  • BRTX 1
  • Target Price
  • YQ N/A
  • BRTX $18.00
  • AVG Volume (30 Days)
  • YQ 8.3K
  • BRTX 1.1M
  • Earning Date
  • YQ 03-19-2025
  • BRTX 03-28-2025
  • Dividend Yield
  • YQ N/A
  • BRTX N/A
  • EPS Growth
  • YQ N/A
  • BRTX N/A
  • EPS
  • YQ N/A
  • BRTX N/A
  • Revenue
  • YQ $28,507,378.00
  • BRTX $377,000.00
  • Revenue This Year
  • YQ N/A
  • BRTX $482.76
  • Revenue Next Year
  • YQ N/A
  • BRTX $212.24
  • P/E Ratio
  • YQ N/A
  • BRTX N/A
  • Revenue Growth
  • YQ 22.55
  • BRTX 189.55
  • 52 Week Low
  • YQ $1.50
  • BRTX $1.03
  • 52 Week High
  • YQ $3.20
  • BRTX $2.55
  • Technical
  • Relative Strength Index (RSI)
  • YQ 52.46
  • BRTX 39.03
  • Support Level
  • YQ $1.86
  • BRTX $1.46
  • Resistance Level
  • YQ $2.04
  • BRTX $1.64
  • Average True Range (ATR)
  • YQ 0.06
  • BRTX 0.26
  • MACD
  • YQ -0.01
  • BRTX -0.04
  • Stochastic Oscillator
  • YQ 37.50
  • BRTX 18.45

About YQ 17 Education & Technology Group Inc.

17 Education & Technology Group Inc is an education technology company in China. It offers to assist students, teachers, schoolmasters, and educational authorities across China to achieve data-driven teaching, learning, and assessment. Geographically group operates in China.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: